Humacyte, Inc. (HUMA) competitors & alternatives
Health Care · NASDAQ
Humacyte, Inc. (HUMA)'s top competitors and alternatives — its most similar public companies — include Medtronic (MDT), LIVANOVA PLC (LIVN), INTEGRA LIFESCIENCES HOLDINGS CORP (IART), LEMAITRE VASCULAR INC (LMAT), Globus Medical (GMED), ARTIVION INC (AORT), ANIKA THERAPEUTICS INC (ANIK), VERICEL CORP (VCEL), 3D SYSTEMS CORP (DDD), MERIT MEDICAL SYSTEMS INC (MMSI), PROKIDNEY CORP CLASS A (PROK) and SURROZEN INC (SRZN). These are Humacyte, Inc.'s closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top HUMA competitors & alternatives
-
MedtronicMDTHealth Care
Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain,…
$81.89 (as of 2026-07-22) · market cap $105.1B
-
LIVANOVA PLCLIVNHealth Care
LivaNova is a medical technology company specializing in innovative cardiovascular and neuromodulation therapies to improve patient lives.
$78.27 (as of 2026-07-22) · market cap $4.3B
-
INTEGRA LIFESCIENCES HOLDINGS CORPIARTHealth Care
Integra LifeSciences is a medical technology company specializing in regenerative medicine, neurosurgery, and advanced surgical instrumentation.
$18.82 (as of 2026-07-22) · market cap $1.5B
-
LEMAITRE VASCULAR INCLMATHealth Care
LeMaitre Vascular develops specialized medical devices and tissue-based solutions for vascular and cardiovascular surgery, targeting an aging population with…
$98.81 (as of 2026-07-22) · market cap $2.3B
-
Globus MedicalGMEDHealth Care
Globus Medical develops spine implants, orthopedic devices, and regenerative tissue biologics to treat musculoskeletal disorders through direct surgeon…
$75.50 (as of 2026-07-22) · market cap $10.3B
-
ARTIVION INCAORTHealth Care
Artivion is a leader in surgical solutions for aortic disease, combining proprietary stent grafts, mechanical heart valves, surgical sealants, and implantable…
$25.14 (as of 2026-07-22) · market cap $1.2B
-
ANIKA THERAPEUTICS INCANIKHealth Care
Anika Therapeutics manufactures and markets hyaluronic acid (HA)-based medical products for orthopedic pain management, tissue regeneration, and non-orthopedic…
$15.01 (as of 2026-07-22) · market cap $199M
-
VERICEL CORPVCELHealth Care
Vericel is a leader in advanced autologous cell therapies for sports medicine and severe burn care, with FDA-approved products MACI for cartilage repair and…
$44.56 (as of 2026-07-22) · market cap $2.4B
-
3D SYSTEMS CORPDDDIndustrials
3D Systems provides an integrated ecosystem of 3D printing hardware, materials, and software enabling healthcare providers and industrial manufacturers to…
$2.66 (as of 2026-07-22) · market cap $448M
-
MERIT MEDICAL SYSTEMS INCMMSIHealth Care
Merit Medical Systems is a diversified medical technology company specializing in high-quality, proprietary devices for interventional and diagnostic…
$73.11 (as of 2026-07-22) · market cap $4.4B
-
PROKIDNEY CORP CLASS APROKHealth Care
ProKidney is pioneering a first-in-class autologous kidney cell therapy to slow kidney function decline in advanced CKD and diabetes patients, currently in…
$1.53 (as of 2026-07-22) · market cap $462M
-
SURROZEN INCSRZNHealth Care
Surrozen is a clinical-stage biotechnology company developing regenerative therapies that harness the body's Wnt signaling pathway to repair tissue damage.
$21.72 (as of 2026-07-22) · market cap $252M
Not quite? Describe exactly what you want →
Peers are Humacyte, Inc.'s closest public companies by shared sub-industry, sector and business themes. See the full profile: Humacyte, Inc. (HUMA).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.